Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Penn biophysicists create new model for protein-cholesterol interactions in brain and muscle tissue

30.09.2008
Biophysicists at the University of Pennsylvania have used 3,200 computer processors and long-established data on cholesterol's role in the function of proteins to clarify the mysterious interaction between cholesterol and neurotransmitter receptors.

The results provide a new model of behavior for the nicotinic acetylcholine receptor, a well studied protein involved in inflammation, Alzheimer's disease, Parkinson's disease, schizophrenia, epilepsy, the effect of general anesthetics and addiction to alcohol, nicotine and cocaine.

Moreover, the results apply to closely related receptors that bind serotonin and GABA, which are neurotransmitters directly involved in regulation of mood and sleep.

The findings have broad implications for, among other fields, pharmacology. Drug development in this arena has to take into account the structure and chemical makeup of this receptor, both of which researchers now say were incomplete. Drugs acting on the receptor have been thought to interact with the protein as though it were isolated.

Now, researchers believe that drugs binding to the receptor not only interact with amino acids — the building blocks of the protein receptor — but also cholesterol tucked away within the protein. The shift in thinking transforms the understanding of this receptor in many ways, from shape and structure to its interaction with its environment and its response to neurotransmitters. The new model should spark a reexamination of several decades of research on the receptor's structure and function.

Researchers demonstrated that the receptor, also know as nAChR, contains internal sites capable of containing cholesterol which serve to stabilize the protein's structure. Furthermore, molecular simulations revealed that both surface sites and deeply buried sites within the protein require cholesterol, which directly supports contacts between the agonist-binding domain and the pores that are thought to be essential for activation of the receptor.

"The result was surprising because, according to most traditional biological models, cholesterol is part of the membrane, not part of the protein," Grace Brannigan, a researcher with the Center for Molecular Modeling at Penn, said. "Our model takes cholesterol out of a background role in the protein's structure and function and puts it on center stage."

Researchers used prior data on how the receptor depends on cholesterol to function plus a computer cluster to run simulations of some 230,000 atoms and their interactions over time. From the raw data, researchers used visualization software to create a model of behavior between the protein and the cholesterol required to function properly.

The study focused on the nicotinic acetylcholine receptor, an ion channel found in both brain and muscle cells. The neurotransmitter acetylcholine, released by upstream nerve cells, binds to portions of the protein on the outside of brain and muscle cells causing the channel to open and allow ions to cross the membrane. Anesthetics, for example, close the channel, which can reduce sensations and cause the memory loss associated with being "put under."

The receptor is a cation-selective channel central to both neuronal and muscular processes and is considered the prototype for ligand-gated ion channels, leading to decades of study to determine its structure. Penn researchers sought to further understand the structure recently determined through cryo-electron microscopy by British and Japanese researchers. Measuring structural details is a difficult task for any protein embedded within a membrane, which can be easily destroyed during the extraction process. The published structure included large, mysterious holes in the protein density.

"It's like looking at the shape of a lock and realizing that you've had the key in your pocket the whole time," Jerome Henin, a researcher with the Center for Molecular Modeling, said. "We found that the holes are the perfect size and shape for cholesterol, which is significant because it has been known for 30 years that this type of protein can only do its job properly if there is cholesterol nearby."

Assuming that cholesterol-shaped holes may indicate a role for cholesterol, researchers began massive simulations on the protein with and without cholesterol present and found that only with cholesterol does the protein behave as expected from experimental data.

This result could also have important implications for understanding recent data indicating that low cholesterol in brain cells has harmful effects on memory, concentration and mood. Twenty-five percent of cholesterol within the body is found in brain cells, where it seems to perform many important roles. Most of the theories for how cholesterol improves the function of brain cells have focused on its effect on the membranes that enclose these cells, but this work suggests that cholesterol may play a much more direct role by burying itself within some of the proteins that are necessary for cells to communicate.

The study was performed by Brannigan, Henin and Michael L. Klein of the Center for Molecular Modeling in the Department of Chemistry at Penn as well as Richard Law of the Lawrence Livermore National Laboratory and Roderic Eckenhoff of the Department of Anesthesiology and Critical Care at the Penn School of Medicine. It was published in the Proceedings of the National Academy of Sciences.

Funding for this research was provided by the National Institutes of Health and the National Science Foundation, with TeraGrid resources provided by the National Center for Supercomputing Applications.

Jordan Reese | EurekAlert!
Further information:
http://www.upenn.edu

More articles from Life Sciences:

nachricht The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences

nachricht Transforming plant cells from generalists to specialists
07.12.2016 | Duke University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Silicon solar cell of ISFH yields 25% efficiency with passivating POLO contacts

08.12.2016 | Power and Electrical Engineering

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>